Browsing: Biliary

Support

Tovecimig/Paclitaxel Meets PFS, Misses OS End Points in 2L Biliary Tract Cancer

By NewsCancerApril 29, 20260

Developers announced secondary end point results from the phase 2/3 COMPANION-002 trial (NCT05506943), which evaluated the treatment combination of tovecimig…

Treatments

FDA Grants Orphan Drug Designation to Tovecimig for Biliary Tract Cancer

By NewsCancerApril 8, 20260

The FDA has granted orphan drug designation to tovecimig (CTX-009) for the treatment of patients with bile duct cancer, according…

Research

PMEPA1 modulates YAP1 nuclear translocation to disrupt EMT subtypes and promote metastasis in Biliary tract cancer

By NewsCancerApril 3, 20260

Valle JW, Kelley RK, Nervi B, Oh D-Y, Zhu AX. Biliary tract cancer. Lancet. 2021;397:428–44. Google Scholar Razumilava N, Gores…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

What Does Practical CAR T Cell Use Look Like in Multiple Myeloma Care?

RASolute-302 Data Signal a New Era for Pancreatic Cancer Drug Development

FDA OKs Lutetium Lu 177 Vipivotide Tetraxetan in Metastatic Prostate Cancer

Browsing: Biliary

Tovecimig/Paclitaxel Meets PFS, Misses OS End Points in 2L Biliary Tract Cancer

FDA Grants Orphan Drug Designation to Tovecimig for Biliary Tract Cancer

PMEPA1 modulates YAP1 nuclear translocation to disrupt EMT subtypes and promote metastasis in Biliary tract cancer

What Does Practical CAR T Cell Use Look Like in Multiple Myeloma Care?

RASolute-302 Data Signal a New Era for Pancreatic Cancer Drug Development

FDA OKs Lutetium Lu 177 Vipivotide Tetraxetan in Metastatic Prostate Cancer

Tumor plasticity in macrophage niches promotes dormancy, EMT and chemoresistance of non-small cell lung cancer stem cells

What Does Practical CAR T Cell Use Look Like in Multiple Myeloma Care?

RASolute-302 Data Signal a New Era for Pancreatic Cancer Drug Development

FDA OKs Lutetium Lu 177 Vipivotide Tetraxetan in Metastatic Prostate Cancer

Tumor plasticity in macrophage niches promotes dormancy, EMT and chemoresistance of non-small cell lung cancer stem cells

Latest Post

What Does Practical CAR T Cell Use Look Like in Multiple Myeloma Care?

RASolute-302 Data Signal a New Era for Pancreatic Cancer Drug Development

FDA OKs Lutetium Lu 177 Vipivotide Tetraxetan in Metastatic Prostate Cancer

Subscribe to Updates

What's Hot

Browsing: Biliary